Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN80601124) titled 'How well is the blood thinner apixaban absorbed in people with short bowel syndrome?' on July 3.
Study Type: Observational
Study Design:
Single-center non-randomized single-arm observational pharmacokinetic study (Other)
Primary Sponsor: General University Hospital in Prague
Condition:
Short bowel syndrome (SBS)
Digestive System
Intervention:
Blood samples were obtained to capture the expected peak plasma steady state concentrations (Tmax) of apixaban in outpatients on standard dose as recommended by the treating physician, in accordance with SmPC, following two different sampling schedules: one sample coll...